✦ LIBER ✦

Subsequent Hematopoietic Stem Cell Transplantation (HSCT) Associated with Longer Survival in Patients with Relapsed/Refractory (R/R) Acute Myelogenous Leukemia (AML) After Clo+Ara-C or Ara-C Alone: A Landmark Analysis from the Classic I Trial

✍ Scribed by S. Ganguly; H.M. Kantarjian; M. Wetzler; D. Rizzieri; G. Schiller; M. Hagasia; R. Stuart; D. Avigan; M. Craig; R. Collins; M. Maris; T. Kovacsovics; S. Golberg; K. Seiter; P. Hari; J. Greiner; N. Vey; C. Recher; F. Ravandi; E. Wang; S. Eckert; A. Partisano; S. Faderl

Book ID: 116282864
Publisher: Elsevier Science
Year: 2012
Tongue: English
Weight: 93 KB
Volume: 18
Category: Article
ISSN: 1083-8791
DOI: 10.1016/j.bbmt.2011.12.026

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Combining Azacitidine (Vidaza®, Aza) and

Combining Azacitidine (Vidaza®, Aza) and Donor Lymphocyte Infusions (DLI) as First Salvage Treatment in Patients (PTS) With Acute Myeloid Leukemia (AML) or Myelodysplastic Syndromes (MDS) Relapsing After Allogeneic Hematopoietic Stem Cell Transplantation (allo-SCT): Interim-Analysis From the Azarela-Trial (NCT-00795548)

✍ T. Schroeder; A.G. Czibere; N. Kröger; U. Platzbecker; G. Bug; L. Uharek; T. Luf 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 63 KB